Enterprise Decision Tool
Batch Release Velocity & ROI Model
Compare manual 300-page paper batch record review timelines against automated algorithmic Review-by-Exception (RBE) with Novaqis Dynamic eBR.
Quantify Your Batch Release Acceleration & ROI
Moving from 300-page manual paper batch record review to Novaqis Dynamic eBR with automated Review-by-Exception cuts batch release cycles from weeks to hours and unlocks trapped working capital.
Combined value of trapped inventory working capital released and eliminated QA paper review overtime.
~98% reduction in release cycle latency.
Equivalent to ~324% of 1 full-time QA auditor.
By enforcing algorithmic limit validation during step execution rather than after manufacturing, unexplained batch discrepancies and post-production OOS investigation backlogs are practically eliminated.
Why Review-by-Exception is the Cornerstone of Pharma 4.0
In standard commercial pharmaceutical manufacturing, finished product batches sit quarantined in warehouses for an average of 10 to 21 days while quality assurance auditors manually inspect hundreds of paper batch binder pages, balance printouts, and logbook entries. This manual review is prone to human oversight, missing initials, and delayed out-of-specification escalations.
4-Hour Release
Algorithms continuously check CPPs and CQAs during manufacturing; QA only reviews flagged exceptions.
21 CFR 211.192
Eliminates unexplained batch discrepancies by preventing out-of-tolerance operations before they happen.
Zero Bypass
Pre-flight handshake with Novaqis eLog™ ensures cleanroom and equipment are certified clean before batch startup.
Want a comprehensive on-site analysis of your plant's batch cycle?
Our validation team can benchmark your current BMR workflow and provide a turn-key eBR migration roadmap.